Skip to main content
. 2019 Aug 22;11(9):1984. doi: 10.3390/nu11091984

Table 1.

Patients’ characteristics.

Parameters Total Type 2 Diabetes Mellitus p-Value +
no (n = 25) yes (n = 25)
Mean ± SD
Number (%)
Mean ± SD
Number (%)
Mean ± SD
Number (%)
Female 40 (80) 19 (76) 21 (84) 0.480
Age (years) 42.2 ± 12.5 35.6 ± 11.9 48.8 ± 9.3 <0.001
BMI (kg/m2) 43.8 ± 4.3 43.7 ± 4.9 43.9 ± 3.7 0.835
Supplementation
Vitamin D 8 (16) 3 (12) 5 (20) 0.440
Iron 1 (2) 0 (0) 1 (4) 0.312
Diuretics use 12 (24) 2 (8) 10 (40) 0.008
Magnesium (mmol/L) 0.81 ± 0.07 0.83 ± 0.05 0.78 ± 0.07 0.006
Deficient (<0.8 mmol/L) 21 (42) 5 (20) 16 (64) 0.002
Glucose (mg/dL) 108.7 ± 36.4 87.6 ± 8.1 129.9 ± 41.3 <0.001
HbA1c (%) 6.0 ± 1.3 5.3 ± 0.5 6.7 ± 1.4 <0.001
OAD use 9 (18) 0 (0) 9 (36) 0.001
Insulin use 6 (12) 0 (0) 6 (24) 0.009
Triglycerides (mg/dL) 155.8 ± 79.8 164.5 ± 89.4 147.2 ± 69.6 0.447
Total cholesterol (mg/dL) 198.2 ± 46.9 197.6 ± 31.9 198.9 ± 59 0.920
HDL cholesterol (mg/dL) 47.3 ± 12.3 46.3 ± 10.3 48.2 ± 14.1 0.578
Cholesterol/HDL ratio 4.4 ± 1.2 4.5 ± 1.3 4.3 ± 1.2 0.573
LDL cholesterol (mg/dL) 120.6 ± 40.3 120 ± 29.9 121.2 ± 48.9 0.916

Body Mass Index (BMI), Hemoglobin A1c (HbA1c), Oral antidiabetic drugs (OAD), High density lipoprotein (HDL), Low density lipoprotein (LDL), + T-test or Chi2-test. A p-value in bold denotes a significant difference (p < 0.05).

HHS Vulnerability Disclosure